TrialThe Journal of infectious diseases2018

Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial.

Geert Leroux-Roels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.